NKTR vs RAPP: stock comparison and AI forecast
Nektar Therapeutics (NKTR) and Rapport Therapeutics, Inc. (RAPP) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
NKTR Nektar Therapeutics
- Price
- $36.95 -57.5% · 6M
- Market Cap
- $1.26B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
RAPP Rapport Therapeutics, Inc.
- Price
- $25.13 -29.3% · 6M
- Market Cap
- $1.21B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- NKTR and RAPP have similar market capitalizations ($1.26B and $1.21B).
- Over the last six months RAPP returned -29.3% and NKTR -57.5%.
- NKTR carries 0.21 times debt per unit of equity, against 0.09 times for RAPP.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | NKTR | RAPP |
|---|---|---|
| Market Cap | $1.26B | $1.21B |
| P/B Ratio | 1.40x | 2.85x |
| EPS | $-6.23 | $-3.30 |
| Book Value/Share | $26.45 | $8.81 |
| Revenue/Share | $1.60 | – |
| FCF/Share | $-6.85 | $-2.02 |
Profitability & Margins
| Metric | NKTR | RAPP |
|---|---|---|
| ROE | -17.4% | -32.4% |
| ROA | -14.3% | -29.9% |
| ROIC | -13.7% | -35.7% |
| Operating Margin | -257.8% | – |
| Net Margin | -287.8% | – |
| EBT Margin | -287.7% | – |
| Tax Rate | -0.0% | – |
Financial Health
| Metric | NKTR | RAPP |
|---|---|---|
| Current Ratio | 10.42x | 15.72x |
| D/E Ratio | 0.21x | 0.09x |
| Financial Leverage | 1.21x | 1.09x |
| Interest Coverage | -120.1x | – |
| Working Capital | $668M | $418M |
Cash Flow
| Metric | NKTR | RAPP |
|---|---|---|
| Operating Cash Flow | -$234M | -$97M |
| Free Cash Flow | -$234M | -$97M |
| Capital Spending | -$240K | -$470K |
| FCF/Sales | -428.7% | – |
| CapEx/Sales | 0.5% | – |
Operational Efficiency
| Metric | NKTR | RAPP |
|---|---|---|
| Asset Turnover | 0.05x | – |
Income Statement
| Metric | NKTR | RAPP |
|---|---|---|
| Total Revenue | $55M | – |
| Operating Income | -$141M | -$154M |
| Net Income | -$157M | -$137M |
| R&D Expense | $132M | $137M |
| Cost of Goods Sold | $0.00M | – |
Dividend & Shareholder Information
| Metric | NKTR | RAPP |
|---|---|---|
| Shares Outstanding | 34M | 48M |
NKTR vs RAPP: stock comparison and AI forecast
Which is bigger, NKTR or RAPP?
NKTR and RAPP have similar market capitalizations ($1.26B and $1.21B).
Which stock performed better over the last six months, NKTR or RAPP?
Over the last six months RAPP returned -29.3% and NKTR -57.5%.
Which one does Intratio's AI model rank higher, NKTR or RAPP?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.